Immunosuppression by micromolecular fibrinogen degradation products in cancer
- 1 February 1976
- journal article
- Published by Springer Science and Business Media LLC in Nature
- Vol. 259 (5542), 399-401
- https://doi.org/10.1038/259399a0
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Immunmechanismen bei UrämieKlinische Wochenschrift, 1975
- Lymphocyte reactivity in pregnant women and newborn infants.BMJ, 1975
- Drug-Induced Immunological Tolerance to Sheep Red Blood Cells in Mice: Effective Combination Therapy with Vincristine and CyclophosphamideInternational Archives of Allergy and Immunology, 1974
- The Fibrinolytic Enzyme System in Malignant LymphomasActa Haematologica, 1973
- 37. ACTION OF FIBRINOGEN DEGRADATION PRODUCTS AND FIBRIN MONOMER SOLUBLE COMPLEXES ON PLATELET AGGREGATIONScandinavian Journal of Haematology, 1971
- CLINICAL EXPERIENCE WITH DETERMINATION OF FIBRINOGEN DEGRADATION PRODUCTSActa Medica Scandinavica, 1971
- EFFECTS ON IN VITRO LYMPHOCYTE FUNCTIONTransplantation, 1969
- The pharmacological properties of fibrinogen degradation productsBritish Journal of Pharmacology, 1969
- Über Immuninsuffizienz bei chronischen, urämischen Nierenerkrankungen*Deutsche Medizinische Wochenschrift (1946), 1969
- Plaque Formation in Agar by Single Antibody-Producing CellsScience, 1963